{"id":"acarbose-tablets","safety":{"commonSideEffects":[{"rate":"20-30","effect":"Gastrointestinal disturbances (flatulence, diarrhea, abdominal discomfort)"},{"rate":"10-20","effect":"Abdominal pain"},{"rate":"15-25","effect":"Diarrhea"},{"rate":"5-10","effect":"Nausea"}]},"_chembl":{"chemblId":"CHEMBL4299399","moleculeType":"Small molecule","molecularWeight":"645.61"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Acarbose is an alpha-glucosidase inhibitor that competitively binds to enzymes responsible for breaking down disaccharides and complex carbohydrates into monosaccharides. By delaying carbohydrate digestion and absorption, it reduces postprandial blood glucose spikes in patients with diabetes. This mechanism helps improve glycemic control without stimulating insulin secretion.","oneSentence":"Acarbose slows the digestion and absorption of carbohydrates in the small intestine by inhibiting alpha-glucosidase enzymes.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:01:21.441Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes mellitus"},{"name":"Postprandial hyperglycemia in patients with diabetes"}]},"trialDetails":[{"nctId":"NCT05487859","phase":"PHASE2","title":"Acarbose in Combination With Standard Therapy in Metastatic Renal Cell Carcinoma (RCC)","status":"WITHDRAWN","sponsor":"University of Alabama at Birmingham","startDate":"2025-12-31","conditions":"Kidney Cancer","enrollment":""},{"nctId":"NCT07122102","phase":"NA","title":"A Multicenter, Randomized, Open-Label, Parallel-Controlled Clinical Study Comparing the Efficacy and Safety of Cofrogliptin Versus Acarbose in Drug-Naïve Patients With Type 2 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Haisco Pharmaceutical Group Co., Ltd.","startDate":"2025-10-01","conditions":"Type 2 Diabetes","enrollment":200},{"nctId":"NCT07074379","phase":"NA","title":"Endotherapy and/or Extracorporeal Shockwave Lithotripsy for Painless Chronic Pancreatitis","status":"RECRUITING","sponsor":"Changhai Hospital","startDate":"2025-07-21","conditions":"Painless Chronic Pancreatitis","enrollment":126},{"nctId":"NCT04877366","phase":"NA","title":"Evaluate Effects of Sprinkled Format REDUCOSE in a Carbohydrate-rich, Mixed Meal on Post-prandial Glycemia","status":"COMPLETED","sponsor":"Société des Produits Nestlé (SPN)","startDate":"2021-07-21","conditions":"Dietary Supplement","enrollment":30},{"nctId":"NCT04665570","phase":"","title":"A Study to Learn More About How Acarbose and Metformin Work When Taken Together and How Safe They Are in Indian Patients Who Were Recently Diagnosed With Type 2 Diabetes (T2D)","status":"COMPLETED","sponsor":"Bayer","startDate":"2020-12-21","conditions":"Type 2 Diabetes Mellitus","enrollment":2000},{"nctId":"NCT06449235","phase":"PHASE4","title":"Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh","status":"NOT_YET_RECRUITING","sponsor":"Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders","startDate":"2024-09","conditions":"Type2diabetes","enrollment":938},{"nctId":"NCT05542849","phase":"PHASE4","title":"The Efficacy and Tolerability of Acarbose in Healthy Individuals","status":"COMPLETED","sponsor":"AgelessRx","startDate":"2022-08-10","conditions":"Tolerance, Side Effect, Glucose Response","enrollment":15},{"nctId":"NCT05629806","phase":"PHASE3","title":"Effect of Acarbose and Mixture of Pioglitazone and Metformin in Patients With Type 2 Diabetes","status":"UNKNOWN","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2022-04-10","conditions":"Type 2 Diabetes, Blood Glucose Fluctuation","enrollment":50},{"nctId":"NCT03359837","phase":"PHASE4","title":"Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin Therapy","status":"COMPLETED","sponsor":"Sanofi","startDate":"2018-01-20","conditions":"Type 2 Diabetes Mellitus","enrollment":384},{"nctId":"NCT03794336","phase":"PHASE4","title":"Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug Naive","status":"COMPLETED","sponsor":"Sanofi","startDate":"2019-06-29","conditions":"Type 2 Diabetes Mellitus","enrollment":1293},{"nctId":"NCT05261997","phase":"NA","title":"Endotherapy for Painless Chronic Pancreatitis","status":"UNKNOWN","sponsor":"Changhai Hospital","startDate":"2022-03","conditions":"Pancreatitis, Chronic, Exocrine Pancreatic Insufficiency, Abdominal Pain","enrollment":60},{"nctId":"NCT01914133","phase":"PHASE2","title":"Acarbose and Older Adults With Postprandial Hypotension","status":"COMPLETED","sponsor":"Kenneth Madden","startDate":"2014-01","conditions":"Other Specified Hypotension, Syncope","enrollment":42},{"nctId":"NCT04065581","phase":"PHASE1","title":"Bioequivalence Study for Acarbose/Metformin FDC","status":"COMPLETED","sponsor":"Bayer","startDate":"2019-10-14","conditions":"Diabetes Mellitus, Type 2","enrollment":24},{"nctId":"NCT03241303","phase":"NA","title":"Delineation of the Role of Glucagon-like Peptide-1 Signalling in Relation to Increased Carbohydrate Content in the Distal Small Intestines","status":"COMPLETED","sponsor":"University Hospital, Gentofte, Copenhagen","startDate":"2017-08-01","conditions":"Glucose Metabolism Disorders","enrollment":15},{"nctId":"NCT04287387","phase":"PHASE4","title":"Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic Agents","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2020-03-02","conditions":"Type2 Diabetes Mellitus","enrollment":180},{"nctId":"NCT02049814","phase":"PHASE4","title":"Efficacy and Safety of Voglibose Compared With Acarbose in Participants With Type 2 Diabetes","status":"COMPLETED","sponsor":"Takeda","startDate":"2014-05-09","conditions":"Type 2 Diabetes Mellitus","enrollment":494},{"nctId":"NCT01709305","phase":"PHASE4","title":"A Study of the Safety and Efficacy of Glimepiride, Gliclazide, Repaglinide or Acarbose When Added to Sitagliptin + Metformin Combination Therapy in Chinese Participants With Diabetes (MK-0431-313)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2012-11-08","conditions":"Type 2 Diabetes Mellitus","enrollment":5570},{"nctId":"NCT01177384","phase":"PHASE3","title":"Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus Receiving Acarbose Monotherapy (MK-0431-130)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2011-01-25","conditions":"Type 2 Diabetes Mellitus","enrollment":380},{"nctId":"NCT02527993","phase":"PHASE4","title":"Treatment of Hypoglycemia Following Gastric Bypass Surgery","status":"COMPLETED","sponsor":"Zealand University Hospital","startDate":"2015-10","conditions":"Hypoglycemia, Obesity, Surgery","enrollment":11},{"nctId":"NCT02273050","phase":"PHASE3","title":"Evaluate the Efficacy and Safety of Saxagliptin in Combination With Metformin IR Compared to Saxagliptin Monotherapy and to Metformin IR Monotherapy in Drug Naive Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2014-12","conditions":"Type 2 Diabetes Mellitus","enrollment":1136},{"nctId":"NCT00829660","phase":"PHASE4","title":"Acarbose Cardiovascular Evaluation Trial","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2009-02-17","conditions":"Coronary Heart Disease, Acute Coronary Syndrome, Impaired Glucose Tolerance","enrollment":6526},{"nctId":"NCT02043886","phase":"PHASE2","title":"Acarbose, Postprandial Hypotension and Type 2 Diabetes","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2007-06","conditions":"Type 2 Diabetes, Postprandial Hypotension","enrollment":15},{"nctId":"NCT02999841","phase":"PHASE4","title":"Effect of Acarbose and Vildagliptin on Visceral Fat Distribution in Newly Diagnosed Type 2 Diabetes Patients","status":"UNKNOWN","sponsor":"Peking University","startDate":"2016-03","conditions":"Diabetes Mellitus, Type 2, Obesity","enrollment":100},{"nctId":"NCT02605772","phase":"PHASE4","title":"Safety and Efficacy of Acarbose+Saxagliptin Compared With Metformin+Saxagliptin in Patients With Type 2 Diabetes","status":"UNKNOWN","sponsor":"Fifth Affiliated Hospital, Sun Yat-Sen University","startDate":"2015-12","conditions":"Type 2 Diabetes Mellitus","enrollment":100},{"nctId":"NCT02587741","phase":"EARLY_PHASE1","title":"Comparison of Diabetes Retinopathy Among Type 2 Diabetic Patients Treated With Different Regimens","status":"UNKNOWN","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2015-07","conditions":"Diabetic Retinopathy","enrollment":600},{"nctId":"NCT01839344","phase":"PHASE2","title":"Effects of Quercetin on Blood Sugar and Blood Vessel Function in Type 2 Diabetes.","status":"COMPLETED","sponsor":"Bastyr University","startDate":"2013-05","conditions":"Diabetes Mellitus, Type 2","enrollment":19},{"nctId":"NCT01219582","phase":"","title":"GLucobay M OBservation Study for Efficacy and Safety in Treatment of Type-2 Diabetes Patients","status":"COMPLETED","sponsor":"Bayer","startDate":"2010-10","conditions":"Type 2 Diabetes","enrollment":9364},{"nctId":"NCT01388153","phase":"PHASE1","title":"A 3-fold Crossover Bioequivalence Study Between Glucobay Orally Disintegrating Tablet (ODT) and Glucobay Standard Tablet","status":"COMPLETED","sponsor":"Bayer","startDate":"2011-06","conditions":"Diabetes Mellitus, Type 2","enrollment":33},{"nctId":"NCT00677521","phase":"PHASE2","title":"A Pilot Study of Acarbose as Treatment for Pediatric Non-alcoholic Fatty Liver Disease (NAFLD)","status":"TERMINATED","sponsor":"The Hospital for Sick Children","startDate":"2007-01","conditions":"Non-alcoholic Fatty Liver Disease","enrollment":1},{"nctId":"NCT01554631","phase":"PHASE1","title":"A 3-fold Crossover Bioequivalence Study Between Glucobay ODT (Orally Disintegrating Tablet) 100 mg and Glucobay Standard Tablet 100 mg","status":"COMPLETED","sponsor":"Bayer","startDate":"2012-03","conditions":"Diabetes Mellitus, Type 2","enrollment":34},{"nctId":"NCT00551954","phase":"PHASE3","title":"Effects of Acarbose on Endothelial Function After a Mixed Meal in Newly Diagnosed Type 2 Diabetes","status":"COMPLETED","sponsor":"Technische Universität Dresden","startDate":"2006-07","conditions":"Type 2 Diabetes","enrollment":""},{"nctId":"NCT01728740","phase":"PHASE1","title":"Bioequivalence Study for Acarbose / Metformin FDC","status":"COMPLETED","sponsor":"Bayer","startDate":"2012-09","conditions":"Diabetes Mellitus, Type II","enrollment":40},{"nctId":"NCT01030952","phase":"PHASE4","title":"Effects of Nateglinide on Postprandial Glucose Excursion by Restoring Early Phase Insulin Secretion","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2009-12","conditions":"Diabetes Mellitus, Type 2","enrollment":103},{"nctId":"NCT01624116","phase":"NA","title":"Comparison of Hypoglycaemic Regimens During Ramadan Fasting in Type 2 Diabetes","status":"COMPLETED","sponsor":"Services Hospital, Lahore","startDate":"2011-08","conditions":"Diabetes, Type 2","enrollment":161},{"nctId":"NCT00928889","phase":"PHASE4","title":"Effects of Nateglinide vs Acarbose on Postprandial Glucose Fluctuation, Dyslipidemia, and Inflammatory Factors","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2009-07","conditions":"Diabetes Mellitus, Type 2","enrollment":160},{"nctId":"NCT01333774","phase":"","title":"Influence of Different Approaches to Dietary Advising on the Effects of Acarbose Treatment in Obese Diabetic Patients Under Real-life Setting","status":"COMPLETED","sponsor":"Bayer","startDate":"2008-05","conditions":"Diabetes Mellitus","enrollment":423},{"nctId":"NCT01245166","phase":"PHASE3","title":"A Phase III Randomized, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg Plus Acarbose 50 mg Tablets) Versus Acarbose Alone in Subjects With Type 2 Diabetes Mellitus","status":"UNKNOWN","sponsor":"Lotus Pharmaceutical","startDate":"2010-11","conditions":"The Objectives of the Study is to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg, Plus Acarbose 50 mg Tablets) Thrice Daily Versus Acarbose 50 mg Thrice Daily Over 16 Weeks in, Subjects With Type 2 Diabetes Mellitus.","enrollment":220},{"nctId":"NCT01167231","phase":"","title":"Prevention of Postprandial Hyperglycemia by Acarbose May be a Promising Therapeutic Strategy for Reducing the Increased Risk for Cardiovascular Disease","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-05","conditions":"Diabetes Mellitus","enrollment":3310}],"_emaApprovals":[],"_faersSignals":[{"count":2,"reaction":"PNEUMONIA"},{"count":1,"reaction":"ABDOMINAL PAIN"},{"count":1,"reaction":"ANAEMIA"},{"count":1,"reaction":"ANGINA UNSTABLE"},{"count":1,"reaction":"BILE DUCT STONE"},{"count":1,"reaction":"BLOOD GLUCOSE INCREASED"},{"count":1,"reaction":"DRUG DOSE OMISSION"},{"count":1,"reaction":"DRUG INEFFECTIVE"},{"count":1,"reaction":"DYSGEUSIA"},{"count":1,"reaction":"ERYTHEMA"}],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Acarbose Tablets","genericName":"Acarbose Tablets","companyName":"University of Alabama at Birmingham","companyId":"university-of-alabama-at-birmingham","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Acarbose slows the digestion and absorption of carbohydrates in the small intestine by inhibiting alpha-glucosidase enzymes. Used for Type 2 diabetes mellitus, Postprandial hyperglycemia in patients with diabetes.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}